Ebbing Lautenbach

Extended-Spectrum  -Lactamase-Producing Escherichia coli and Klebsiella pneumoniae: Risk Factors for Infection and Impact of Resistance on Outcomes

Ebbing Lautenbach, Jean B. Patel, Warren B. Bilker et al. · Clinical Infectious Diseases · 2001 · 749 citations · Full text

Antimicrobial Resistance Gene, Antimicrobial Susceptibility, Health Sciences +14

Absence of Cross-Reactivity between Sulfonamide Antibiotics and Sulfonamide Nonantibiotics

Brian L. Strom, Rita Schinnar, Andrea J. Apter et al. · New England Journal of Medicine · 2003 · 339 citations · Full text

Desirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR)

Scott Evans, Daniel B. Rubin, Dean Follmann et al. · Clinical Infectious Diseases · 2015 · 323 citations · Full text

Patient Selection, Antibiotic Resistance, Drug Resistance +22

Carbapenem Therapy Is Associated With Improved Survival Compared With Piperacillin-Tazobactam for Patients With Extended-Spectrum β-Lactamase Bacteremia

Pranita D. Tamma, Jennifer Han, Clare Rock et al. · Clinical Infectious Diseases · 2015 · 318 citations · Full text

Risk Factors and Clinical Impact of <i>Klebsiella pneumoniae</i> Carbapenemase-Producing <i>K. pneumoniae</i>

Leanne B. Gasink, Paul H. Edelstein, Ebbing Lautenbach et al. · Infection Control and Hospital Epidemiology · 2009 · 308 citations · Full text